After more than a year of limping along, Eden Bioscience said Friday that it will liquidate its assets. The Woodinville-based agricultural science...
After more than a year of limping along, Eden Bioscience said Friday that it will liquidate its assets.
The Woodinville-based agricultural science company said it plans an “orderly wind down” if shareholders agree. The dissolution will meet or settle the company’s remaining debts, distribute cash among the company’s shareholders, and take its ticker off Nasdaq.
The company has been looking for alternatives to help it survive since it sold off a significant part of its assets in February 2007, but the board of directors concluded that liquidation was the best strategy.
The news pushed the company’s stock up 61 cents, or 77 percent, to $1.40 Friday.
Most Read Business Stories
- The penthouse atop Smith Tower is on the rental market for the first time
- Downtowns will be back, but Seattle has choices to make
- Washington state ‘literally failed workers,’ and fixing the unemployment system won't be easy
- Boutique cruise line Windstar will move its Seattle headquarters to Miami
- J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine